June 4, 2019 – Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Medical Oncologist and Hematologist, Barry S. Berman, MD has joined joined the statewide practice and will be seeing patients in two offices, including West Palm Beach (1309 North Flagler Drive, West Palm Beach, Florida 33401) and Wellington North (1037 South State Road 7, Suite 303, Wellington, Florida 33414).
FCS CEO, Brad Prechtl, MBA said, “We are committed to providing personalized treatments to our patients in the most advanced setting that is convenient and close to home. Dr. Berman’s expertise and experience will make him a perfect fit for the FCS family."
Dr. Lucio N. Gordan, President & Managing Physician of FCS, added, “We are delighted to welcome Dr. Berman to Florida Cancer Specialists. He comes to us with more than 25 years of experience in medical oncology/hematology, making him both beneficial to our team and our patients in Palm Beach County”.
Board-certified in medical oncology, hematology, and internal medicine, Dr. Berman earned his medical degree from the University of South Florida College of Medicine, received his internal medicine training at the University of South Florida, and completed his fellowship in medical oncology and hematology at the University of South Florida, H. Lee Moffitt Cancer Center.
Serving many years as a board member for the Florida Society of Clinical Oncology (FLASCO), Dr. Berman also held positions as Clinical Practice Committee Chair, Vice President, Secretary and Treasurer for FLASCO. He has also served on the American Society of Clinical Oncology (ASCO) Practice Guideline Implementation Network (PGIN) Committee since 2015 and was an author on three of the current guidelines. He also served as chair of the Investigational Review Board at Broward Health.
As a cancer researcher, Dr. Berman has been actively engaged in multiple clinical studies over the last 25 years and has been published in a number of peer-reviewed journals
Dr. Berman is a member of the American Society of Clinical Oncology, Florida Society of Clinical Oncology, American Medical Association, American Society of Internal Medicine, American College of Physicians and the Southern Association of Oncology.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering.
Founded in 1984, FCS is one of the largest medical oncology/hematology practices in the United States. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help targeted treatments and genomic-based treatment and immunotherapy. These values are embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
